July 6, 2021
FDA: Class I recall of Medtronic angiographic guidewire
Editor's Note
The Food and Drug Administration (FDA) on July 2 identified the recall by Medtronic Vascular of its angiographic guidewire component as Class I, the most serious.
The recall was initiated because the devices were not sterilized before being shipped to hospitals.
The guidewire is used during angiography or other interventional procedures to help place catheters into the vasculature.
There have been 2 complaints and no reported injuries or deaths. Distribution dates were November 23, 2007, to March 29, 2021.
Free Daily News
- 5 reasons why perioperative leaders deserve to attend the 2025 OR Manager Conference
- Global medical community rejects Trump’s Tylenol-autism claims: Statements compilation
- Surgery, implantable devices offer new hope for drug-resistant epilepsy
- Remote monitoring speeds recovery, lowers complications after cancer surgery
- Common supplements may heighten bleeding risk during surgery, Polish study finds
- Keeping sensory aids in place during surgery reduces delirium risk in older hip fracture patients
- HFMA warns affordability crisis is driving up provider bad debt
- Report warns sterile processing staffing crisis threatens surgical safety
- Ascension swings to profit as outpatient push, cost cuts take hold
- High BMI alone did not raise early complication risk after outpatient TJA
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement